Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Up Front MattersEditorials
You have accessRestricted Access

We AIM2 Inflame

Andreas Linkermann, Simon P. Parmentier and Christian Hugo
JASN April 2018, 29 (4) 1077-1079; DOI: https://doi.org/10.1681/ASN.2018020116
Andreas Linkermann
Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon P. Parmentier
Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Hugo
Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading
  • necroptosis
  • ferroptosis
  • pyroptosis
  • apoptosis
  • Inflammasome

The AIM2 inflammasome senses DNA released by necrotic renal cells and translates a deadly signal into a proinflammatory trigger, thereby providing a prototype example of necroinflammation. Loss of cellular membrane integrity (necrosis) represents a genetically determined and highly regulated process during AKI.1 During recent years, a discussion on the role of regulated necrosis as a novel therapeutic target during transplantation has emerged, but interestingly not because interference with necrotic cell death might preserve renal cell survival. Prevention of necrosis rather prevents the immunogenicity of necrotic debris. When any cell loses its membrane integrity, two steps follow. First, this cell loses most of its function. In the case of a tubular cell, this may represent features of AKI. Second, intracellular debris (often referred to as damage-associated molecular patterns2,3) becomes accessible to surveilling immune cells. In the case of kidney transplantation, such cells become strongly activated and primed (e.g., in the case of B cells).4 On immunosuppression during the transplant process, immediate immunogenic responses (rejections) are prevented. When immunosuppression is tapered months after transplantation, antibody-mediated rejections may then be triggered, e.g., after otherwise trivial viral infection.4 But how can necrotic debris conceptually be explained as the stimulating trigger of macrophages on a molecular level? An important set of well controlled data regarding this long-standing obstacle now comes from the group of Daniel Muruve.5

In this issue of the Journal of the American Society of Nephrology, Komada et al.5 detected expression levels of the inflammasomal protein absent in melanoma 2 (AIM2) in human kidney sections obtained from nondiseased margins of nephrectomies in which AIM2 is predominantly present in the glomeruli. However, in samples obtained from patients with diabetic nephropathy or hypertensive sclerosis, a strong upregulation of AIM2 expression in infiltrating CD45-positive leukocytes and in the tubular compartment was demonstrated. These human findings were in line with data generated from mice that underwent unilateral ureteral obstruction (UUO). In those samples of either whole kidney lysates or microdissected tubular and glomerular compartments, AIM2 mRNA and AIM2-knockout (AIM2-ko) controlled protein expressions were highly upregulated. The AIM2 data are particularly interesting because previous work on inflammasomes in the kidney demonstrated the involvement of another type of inflammasomes, the so-called NLRP3 inflammasome.6 Consequently, the authors compared NLRP3-deficient and AIM2-deficient mice alongside with NLRP3/AIM2 double knockout (NLRP3/AIM2-dko) mice in the UUO model. Interestingly, after 7 days of UUO treatment, similar levels of protection were reported for all three genetic models in tubular injury scores and KIM1 protein expression, suggesting a partially redundant role for the inflammasomes during renal damage. However, whereas KIM1 gene expression appeared to be remarkably reduced in the NLRP3/AIM2-dko mice compared with AIM2-ko mice or wild-type controls, these knockout mice did not show a significant difference in renal fibrosis, as measured by picrosirius red staining or collagen I expression. Such a faint interplay between NLRP3 and AIM2 has recently been described during Aspergillus infection.7

The authors next investigated the role of F4/80-positive macrophages. Whereas an almost six-fold higher F4/80-positive area was found in UUO-treated wild-type mice compared with untreated controls, this increase was reduced by approximately 50% in AIM2-ko and NLRP3/AIM2-dko mice, highlighting the role of macrophages in this model. Importantly, effector functions of inflammasomes are mediated though caspases (caspase-1, -4, -5, and -11) through proteolytic cleavage of pro–IL-1β and pro–IL-18. Clearly, the IL1β-to-pro–IL-1β and the IL-18-to-pro–IL-18 ratios were decreased in both AIM2-ko and NLRP3/AIM2-dko UUO kidney samples compared with wild-type UUO. This finding suggests the proinflammatory role of inflammasomal signaling to be significantly reduced in the knockout mice. In keeping with the hypothesis that the AIM2 inflammasome in macrophages contributes to renal damage during UUO, bone marrow transfer experiments in which wild-type bone marrow was transplanted to AIM2-deficient mice brought the dimension of injury back to wild-type control levels. This experiment excluded a significant pathophysiologic role of AIM2 in the tubular cell compartment.

Elegant FACS studies employing CD45/F4/80 double-positive gating of kidney-derived samples revealed high levels of proinflammatory chemokines, such as CX3CR1 and CCR2 only in cells derived from wild-type mice, but not in AIM2-ko or NLRP3/AIM2-dko mice. The presence of these cells and their activity suggested AIM2 stimulation in this tissue by DNA,8 the source of which most likely were necrotic tubular cells. To this end, the authors used macrophage lineage specific LysM;cre mice that were transfected with a green fluorescent protein (gfp). Additional staining for DNA by SYTOX orange allowed for direct detection of DNA released from tubular cells to be taken up by LysM-gfp–positive cells with two-photon intravital microscopy. These experiments clearly demonstrate the uptake of necrotic cell released DNA by renal macrophages in living animals. However, the authors decided to add yet another line of evidence by treating THP1 cells (a macrophage cell line) with DNA generated from necrotic human tubular epithelial cells. Within 2 hours, the DNA released by the necrotic cell was taken up by the THP1 cells and IL-1β release was demonstrated to be highly increased in a caspase-sensitive manner. As expected, addition of DNase to the media destroyed the human tubular epithelial cell DNA and prevented the increased release of IL-1β.

Necrosis of renal tubular cells has recently been identified as a major driver of acute kidney injury in models of cisplatin-induced nephrotoxicity, folic acid–induced nephropathy, ischemia–reperfusion injury, and during kidney transplantation.1 As now demonstrated by Komada et al.,5 necrotic DNA is sensed, at least partially, by the AIM2 inflammasome to drive macrophage IL-1β release (Figure 1). These experiments support the model of necroinflammation (necrosis-driven potentiation of the initial damage by infiltrating immune cells).9,10 Two therapeutic options evolve from these findings. First, it should be possible to prevent the necrotic cell death per se. Second, if necrosis cannot be prevented, targeting inflammasomes provides an attractive alternative, but until now, no promising drug candidates are broadly available, to the best of our knowledge.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

AIM2-mediated sensing of DNA released from necrotic cells. Upon acute tubular necrosis, tubular cells release intracellular content. This necrotic debris contains damage-associated molecular patterns (DAMPs) such as DNA. Macrophages sense DNA released from necrotic cells through the AIM2 inflammasome and subsequently produce proinflammatory cytokines, such as IL-1β and IL-18. The amplification of the immunogenicity of a necrotic DAMP into a stronger proinflammatory signal is referred to as necroinflammation.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related article, “Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD,” on pages 1165–1181.

  • Copyright © 2018 by the American Society of Nephrology

References

  1. ↵
    1. Linkermann A
    : Nonapoptotic cell death in acute kidney injury and transplantation. Kidney Int 89: 46–57, 2016
    OpenUrlCrossRefPubMed
  2. ↵
    1. Land WG,
    2. Agostinis P,
    3. Gasser S,
    4. Garg AD,
    5. Linkermann A
    : DAMP-induced allograft and tumor rejection: The circle is closing. Am J Transplant 16: 3322–3337, 2016
    OpenUrlPubMed
  3. ↵
    1. Land WG,
    2. Agostinis P,
    3. Gasser S,
    4. Garg AD,
    5. Linkermann A
    : Transplantation and Damage-Associated Molecular Patterns (DAMPs). Am J Transplant 16: 3338–3361, 2016
    OpenUrl
  4. ↵
    1. Sarhan M,
    2. von Mässenhausen A,
    3. Hugo C,
    4. Oberbauer R,
    5. Linkermann A
    : Immunological consequences of kidney cell death. Cell Death Dis 9: 114, 2018
    OpenUrlCrossRef
  5. ↵
    1. Komada T,
    2. Chung H,
    3. Lau A,
    4. Platnich JM,
    5. Beck PL,
    6. Benediktsson H, et al
    : Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD. J Am Soc Nephrol 29: 1165–1181, 2018
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Anders HJ,
    2. Muruve DA
    : The inflammasomes in kidney disease. J Am Soc Nephrol 22: 1007–1018, 2011
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Karki R,
    2. Man SM,
    3. Malireddi RK,
    4. Gurung P,
    5. Vogel P,
    6. Lamkanfi M, et al
    .: Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe 17: 357–368, 2015
    OpenUrlCrossRefPubMed
  8. ↵
    1. Fernandes-Alnemri T,
    2. Yu JW,
    3. Datta P,
    4. Wu J,
    5. Alnemri ES
    : AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509–513, 2009
    OpenUrlCrossRefPubMed
  9. ↵
    1. Linkermann A,
    2. Stockwell BR,
    3. Krautwald S,
    4. Anders HJ
    : Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat Rev Immunol 14: 759–767, 2014
    OpenUrlCrossRefPubMed
  10. ↵
    1. Mulay SR,
    2. Linkermann A,
    3. Anders HJ
    : Necroinflammation in kidney disease. J Am Soc Nephrol 27: 27–39, 2016
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 29 (4)
Journal of the American Society of Nephrology
Vol. 29, Issue 4
April 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
We AIM2 Inflame
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
We AIM2 Inflame
Andreas Linkermann, Simon P. Parmentier, Christian Hugo
JASN Apr 2018, 29 (4) 1077-1079; DOI: 10.1681/ASN.2018020116

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
We AIM2 Inflame
Andreas Linkermann, Simon P. Parmentier, Christian Hugo
JASN Apr 2018, 29 (4) 1077-1079; DOI: 10.1681/ASN.2018020116
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Up Front Matters

  • COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation
  • The Aftermath of AKI: Recurrent AKI, Acute Kidney Disease, and CKD Progression
  • Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
Show more Up Front Matters

Editorials

  • COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation
  • The Aftermath of AKI: Recurrent AKI, Acute Kidney Disease, and CKD Progression
  • Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD
  • PubMed
  • Google Scholar

Keywords

  • necroptosis
  • ferroptosis
  • pyroptosis
  • apoptosis
  • Inflammasome

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire